People: Zurich Insurance Group AG (ZURN.VX)

ZURN.VX on Virt-X Level 1

301.60CHF
17 Apr 2015
Change (% chg)

CHF-5.80 (-1.89%)
Prev Close
CHF307.40
Open
CHF308.60
Day's High
CHF308.70
Day's Low
CHF301.60
Volume
817,263
Avg. Vol
648,664
52-wk High
CHF334.60
52-wk Low
CHF246.90

Search Stocks

de Swaan, Tom 

Dr. Tom de Swaan has been appointed Chairman of the Board of Zurich Insurance Group AG effective September 2013. He is Chairperson of the Governance and Nominations Committee, Member of the Remuneration Committee. Prior to that, he served as Acting Chairman of the Board at Zurich Insurance Group AG effective August 29, 2013. Prior to that, he was Non-Executive Member of the Board of Directors of Zurich Insurance Group AG since April 20, 2006. He is Member of the Board of Directors and Chairman of the Audit Committee of Zurich Insurance plc. He joined De Nederlandsche Bank N.V., in 1972, and, from 1986 until 1998, has served as Member of the Governing Board. In January 1999, he became Member of the Managing Board and Chief Financial Officer of ABN AMRO Bank. He retired from ABN AMRO, on May 1, 2006, but continued as Adviser to the Managing Board until June 2007. Dr. de Swaan is Non-Executive Member of the Board of GlaxoSmithKline Plc and Chairman of its Audit Committee. He is Member of the Supervisory Board of Royal DSM. Since May 10, 2008, he is Chairman of the Supervisory Board of Van Lanschot NV. From 1987 to 1988, he has served as Chairman of the Amsterdam Financial Center and, from 1995 to 1997, Chairman of the Banking Supervisory Sub-Committee of the European Monetary Institute. He was also Member of the Basel Committee on Banking Supervision, from 1991 to 1996, its Chairman, from 1997 to 1998, and Non-Executive Director on the Board of the United Kingdom’s Financial Services Authority from January 2001 until the end of 2006. Dr. de Swaan is also Director of a number of non-profit organizations. Among others, he is Treasurer of the Board of the Royal Concertgebouw Orchestra, the Netherlands Cancer Institute and the International Franz Liszt Piano Competition. Moreover, he chairs the Advisory Board of the Rotterdam School of Management. Dr. de Swaan graduated from the Universiteit van Amsterdam with a Masters degree in Economics.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
1,000,000 -- 60,000 1,060,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tom de Swaan

1,060,000

Martin Senn

7,600,000

Fred Kindle

375,000

George Quinn

--

Robert Dickie

--

Isabelle Welton

--
As Of  30 Dec 2014
Search Stocks